Accessibility Menu

Investing in Genomics Stocks

By Lyle DalyUpdated Oct 7, 2025 at 12:02 AM | Fact-checked by Frank Bass

Key Points

  • Natera uses AI to boost clinical decisions, showing a 32% revenue increase and more test processing.
  • Avidity Biosciences focuses on RNA therapeutics for rare muscle diseases, with FDA breakthroughs.
  • Quest Diagnostics offers a robust genetic testing suite, displaying strong profits and dividends.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.